AT-07 A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: PATIENT REPORTED OUTCOMES (PRO) FROM A CERN CLINICAL TRIAL

類似資料

• AT-23 A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: A CERN CLINICAL TRIAL
  著者:: Gilbert, Mark, 等
  出版事項: (2014)
• RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB
  著者:: Armstrong, Terri, 等
  出版事項: (2018)
• A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma
  著者:: Gilbert, Mark R, 等
  出版事項: (2020)
• Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients
  著者:: Vera-Bolanos, Elizabeth, 等
  出版事項: (2015)
• QL-01 ANXIETY, DEPRESSION AND ANGER IN CHILDREN WITH EPENDYMOMA: A REPORT FROM THE COLLABORATIVE EPENDYMOMA RESEARCH NETWORK (CERN) PEDIATRIC OUTCOMES PROJECT (PEO)
  著者:: Acquaye, Alvina, 等
  出版事項: (2014)